Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-15, Stock:JNJ, The news for the past five days is as follows:
2021-11-08: NEWS1: U.S. administers 432 mln COVID-19 vaccine doses, 70% adults fully vaccinated- CDC.NEWS2: IBD/TIPP Poll: Vaccine Holdouts Dig In With Pfizer, Merck Antiviral Pills Looming.NEWS3: Travel 'confidence level' is surging amid COVID-19 vaccinations: Vacasa CEO.NEWS4: Coronavirus: Infectious diseases physician details the latest news and therapeutics in pandemic.NEWS5: 10 Dividend ETFs to Buy Now.NEWS6: Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q2.NEWS7: COVID testing costs, hospitalization to drop as treatments enter market: Analyst.NEWS8: 2 Leading Healthcare Stocks to Buy in 2021 and Beyond.
2021-11-09: NEWS1: Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson.NEWS2: Johnson & Johnson Opioid Verdict Overturned by Oklahoma Supreme Court.NEWS3: Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards.NEWS4: U.S. administers 433.2 mln doses of COVID-19 vaccines - CDC.NEWS5: Janssen Partially Terminates Nanoparticle License Agreement With Alkermes.NEWS6: UPDATE 4-Oklahoma court overturns $465 mln opioid judgment against J&J.NEWS7: Oklahoma court overturns $465 million opioid judgment against J&J.NEWS8: Oklahoma court overturns $465 million opioid award against Johnson & Johnson.NEWS9: Why Alkermes Stock Is Sinking Today.NEWS10: Wave of Solid Q3 Earnings Push Pharma ETFs Higher.NEWS11: Oklahoma Court Overturns Opioid Judgement Against J&J.NEWS12: The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data.NEWS13: Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?.
2021-11-10: NEWS1: Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer.NEWS2: Dr. Sanjay Gupta on combating COVID-19 vaccine misinformation.NEWS3: U.S. administers 434.5 mln doses of COVID-19 vaccines - CDC.NEWS4: J&J Baby Powder Bankruptcy Moved to N.J. Despite ‘Texas Two-Step’.NEWS5: UPDATE 3-U.S. judge temporarily halts Johnson & Johnson talc cases, moves them to New Jersey.NEWS6: U.S. judge temporarily halts Johnson & Johnson talc cases, moves them to New Jersey.NEWS7: Novavax asks for FDA meeting after first global authorization for COVID-19 vaccine: CEO.NEWS8: J&J Wins Halt to 38,000 Baby Powder Lawsuits Amid Bankruptcy.NEWS9: Oklahoma Supreme Court Tosses Opioid Award Against J&J.NEWS10: Oklahoma Supreme Court Overturns Opioid Ruling Against Johnson & Johnson.NEWS11: Novavax CEO: We aim to complete the FDA filing for our COVID vaccine this year.NEWS12: Pfizer asks the FDA to authorize its COVID booster shot for adults.NEWS13: UPDATE 3-U.S. brokers J&J-COVAX deal to send vaccines to conflict zones -Blinken.NEWS14: 3 Rock-Solid Healthcare Dividend Stocks Now on Sale.NEWS15: Judge to rule on request to halt Johnson & Johnson talc lawsuits.NEWS16: J&J Lauds Oklahoma Ruling That Tosses Out $465 Million Opioid Judgment.
2021-11-11: NEWS1: Next Level Benefits CEO: 'Employers are going to need to pay for' COVID-19 testing at work.NEWS2: EU Lists Spinal Cord Inflammation Probable Side Effect Of JNJ's COVID-19 Shot: Reuters.NEWS3: UPDATE 1-EU lists rare spinal condition as side-effect of J&J COVID-19 shot.NEWS4: Stock Dividends Are About to Set a Record. Here’s Where to Snag 3% Yields..NEWS5: Pfizer making 'misleading' claims about vaccine distribution, says Amnesty International.
2021-11-12: NEWS1: General Electric, Tesla, Disney: Stocks That Defined the Week.NEWS2: One in three Americans aged 65 and above has got COVID-19 booster shot: CDC.NEWS3: Best way to minimize COVID-19 risk this holiday season is by getting vaccinated: Doctor.NEWS4: Why Johnson & Johnson Stock Rose Today.NEWS5: GE, J&J Breakups Add More Fuel to the Dealmaking Fire for Banks.NEWS6: Johnson & Johnson Pops As It Announces The Biggest Split In Health Care.NEWS7: Johnson & Johnson Plans to Split Into Two Companies.NEWS8: Moderna vaccine patent dispute: 'It’s a political story. It’s a financial story. It’s a legal story’.NEWS9: Johnson & Johnson Is Becoming Two Companies. What Happens to My Stock?.NEWS10: US STOCKS-Wall Street advances, powered by big tech.NEWS11: J&J’s Corporate Split: Just Another Big, Blue-Chip Breakup.NEWS12: J&J split will put spotlight on undervalued pipeline, CFO says.NEWS13: Coronavirus: Doctor sees ‘beginning of a wave’ as winter looms.NEWS14: Reactions to J&J's plans to split into two companies.NEWS15: Doctor's holiday gathering advice amid pandemic: 'Being vaccinated goes a long way'.NEWS16: QUOTEBOX-Reactions to J&J's plans to split into two companies.NEWS17: Johnson & Johnson (JNJ) Splitting Into Two Companies.NEWS18: Why Johnson & Johnson is splitting its drugs from its deodorants.NEWS19: US STOCKS-Wall Street powers higher on J&J, Big Tech boost.NEWS20: Johnson & Johnson Breakup Is No Clean Sweep.NEWS21: The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst.NEWS22: Factbox-J&J's legal liabilities as it plans to split.NEWS23: Stocks End Higher on Johnson & Johnson Spin-Off, Down for the Week.NEWS24: Johnson & Johnson Stock Is Gaining Because 2 Companies Might Make More Sense Than 1.NEWS25: Stock Market Rally Cools On Hot Inflation; Rivian IPO Revs Higher, Elon Musk Sells Tesla Shares; GE, J&J Plan Breakups: Weekly Review.NEWS26: Health-Care Giant J&J to Split Into Drug and Consumer Companies.NEWS27: Pre-Markets Edge Up on JNJ Split News.NEWS28: Four Big Takeaways From Johnson & Johnson’s Plans to Break Apart.NEWS29: Biden and Xi to meet virtually, AstraZeneca begins profiting off COVID vaccines, General Mills eyes sale of brands.NEWS30: Johnson & Johnson, with thousands of Philadelphia-area employees, to split into 2 companies.NEWS31: Dow Jones Leads As J&J Stock Rallies; Rivian IPO Revs Up, While Tesla Skids.NEWS32: US STOCKS-Wall Street rises on J&J, Big Tech boost.NEWS33: Johnson & Johnson Stock Rises on Plan for Breakup.NEWS34: Johnson & Johnson and Toshiba Just Followed GE’s Lead With Split Plans. Don’t Mourn the Conglomerate..NEWS35: Factbox-J&J's legal strategy for Baby Powder, talc liability.NEWS36: Factbox: Baby Powder to Band-Aid: Key facts on J&J's consumer health business.NEWS37: Johnson & Johnson CFO: Splitting company into two is about 'the potential unlocking of value for the consumer health business'.NEWS38: J&J Plans to Split in Two; Dow Up Triple Digits.NEWS39: Dow Jones Rallies As J&J Jumps On Breakup Plans; Tesla Falls, Rivian Races Higher.NEWS40: Johnson & Johnson  to split into two companies, consumer products and medical devices.NEWS41: Dow Jones Futures Rise As J&J Jumps On Breakup Plans; Rivian Set To Extend Rally.NEWS42: Johnson & Johnson Stock Jumps on Plan for Breakup.NEWS43: Johnson & Johnson To Spin Off Consumer Health Business: What You Need To Know.NEWS44: Johnson & Johnson to spin off consumer health unit from medical device and drug-making division.NEWS45: The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares.NEWS46: Wall Street rises on J&J, Big Tech boost.NEWS47: Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy.NEWS48: Johnson & Johnson, Toshiba Follow GE With Split Plans. But the Conglomerate Is Far From Dead..NEWS49: J&J plans to split into two public companies and separate consumer and drug businesses.NEWS50: Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business.NEWS51: Healthcare giant Johnson & Johnson to split into two companies.NEWS52: Johnson & Johnson to split into two to focus on drugs.NEWS53: Johnson & Johnson Break-Up May Put Triple-A Credit Rating At Risk - Moody's.NEWS54: Premarket Movers Friday - Johnson & Johnson, Rivian, Nvidia.NEWS55: Johnson & Johnson Spin-Off Powers Dow Futures; Stocks Eye Bond Market Return Amid Inflation Jitters.NEWS56: J&J Pops on Decision to Split Consumer Health Business.NEWS57: Dow Futures Rise 110 Pts; Chinese Retail Giants, J&J in Focus.NEWS58: Johnson & Johnson Stock Leaps On Plan to Split Into Two Separate Companies.

Answer: Decrease